Home LiteratureArticle Details
PMID: 3937731 Published · ppublish English Clinical Trial Journal Article

Status of a group B Neisseria meningitidis vaccine.

European journal of clinical microbiology ·Vol. 4 ·No. 6 ·1985-12-00 ·Pages 533-6

Frasch CE

Abstract

暂无摘要

MeSH Terms
Adjuvants, Immunologic Adult Animals Antibodies, Bacterial/immunology Antigens, Bacterial/immunology Bacterial Capsules Bacterial Outer Membrane Proteins/immunology Bacterial Vaccines/immunology Child Child, Preschool Clinical Trials as Topic Double-Blind Method Humans Infant Meningitis, Meningococcal/immunology,prevention & control Meningococcal Vaccines Neisseria meningitidis/classification,immunology,pathogenicity Polysaccharides, Bacterial/immunology Random Allocation Serotyping Vaccination
Chemicals
Adjuvants, Immunologic Antibodies, Bacterial Antigens, Bacterial Bacterial Outer Membrane Proteins Bacterial Vaccines Meningococcal Vaccines Polysaccharides, Bacterial capsular polysaccharide, meningococcal group B
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Frasch C E
References (24)
24 references, click to expand
  1. Experimental meningococcal infection in neonatal mice: differences in virulence between strains isolated from human cases and carriers.
    Can J Microbiol. 1984 Aug;30(8):1042-5 PMID: 6437654
  2. Development of a Neisseria meningitidis group B serotype 2b protein vaccine and evaluation in a mouse model.
    Infect Immun. 1984 Nov;46(2):408-14 PMID: 6437983
  3. Clinical and serological evaluation of a meningococcal polysaccharide vaccine groups A, C, Y, and W135.
    Proc Soc Exp Biol Med. 1982 Jan;169(1):54-7 PMID: 6801667
  4. Protection against group B meningococcal disease: evaluation of serotype 2 protein vaccines in a mouse bacteremia model.
    Infect Immun. 1979 Oct;26(1):110-7 PMID: 115794
  5. Monoclonal antibody that recognizes an outer membrane antigen common to the pathogenic Neisseria species but not to most nonpathogenic Neisseria species.
    Infect Immun. 1984 Mar;43(3):994-9 PMID: 6421742
  6. Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis.
    Lancet. 1983 Aug 13;2(8346):355-7 PMID: 6135869
  7. Immunochemistry of groups A, B, and C meningococcal polysaccharide-tetanus toxoid conjugates.
    J Immunol. 1981 Sep;127(3):1011-8 PMID: 6790606
  8. Immunologic response of man to group B meningococcal polysaccharide vaccines.
    J Infect Dis. 1972 Nov;126(5):514-21 PMID: 4197754
  9. Safety and immunogenicity of a Neisseria meningitidis type 2 protein vaccine in animals and humans.
    J Infect Dis. 1978 Jun;137(6):728-39 PMID: 77885
  10. Protection against group B meningococcal disease. III. Immunogenicity of serotype 2 vaccines and specificity of protection in a guinea pig model.
    J Exp Med. 1978 Mar 1;147(3):629-44 PMID: 416164
  11. Protection against group B Neisseria meningitidis disease: preparation of soluble protein and protein-polysaccharide immunogens.
    Infect Immun. 1982 Jul;37(1):271-80 PMID: 6809629
  12. Response of Neisseria gonorrhoeae to iron limitation: alterations in expression of membrane proteins without apparent siderophore production.
    Infect Immun. 1985 Feb;47(2):388-94 PMID: 3155708
  13. Conjugation of meningococcal lipopolysaccharide R-type oligosaccharides to tetanus toxoid as route to a potential vaccine against group B Neisseria meningitidis.
    Infect Immun. 1984 Jan;43(1):407-12 PMID: 6418661
  14. Serotypes of Neisseria meningitidis isolated from patients in Norway during the first six months of 1978.
    J Clin Microbiol. 1979 Feb;9(2):186-8 PMID: 107188
  15. Protection against group B Neisseria meningitidis disease: effect of serogroup B polysaccharide and polymyxin B on immunogenicity of serotype protein preparations.
    Infect Immun. 1982 Jul;37(1):264-70 PMID: 6809628
  16. Meningococcal meningitis in Royal Air Force recruits.
    Public Health. 1977 Sep;91(5):253-7 PMID: 905498
  17. Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes.
    Rev Infect Dis. 1985 Jul-Aug;7(4):504-10 PMID: 2412271
  18. Complex of meningococcal group B polysaccharide and type 2 outer membrane protein immunogenic in man.
    J Clin Invest. 1979 May;63(5):836-48 PMID: 109466
  19. Meningococcal disease: still with us.
    Rev Infect Dis. 1983 Jan-Feb;5(1):71-91 PMID: 6338571
  20. Monoclonal antibodies to serotype 2 and serotype 15 outer membrane proteins of Neisseria meningitidis and their use in serotyping.
    Infect Immun. 1984 Oct;46(1):260-6 PMID: 6434428
  21. Serotypes and polyacrylamide gel electrophoresis types among disease-associated isolates of group B Neisseria meningitidis in Spain, 1976-1979.
    J Infect Dis. 1983 Aug;148(2):249-53 PMID: 6411831
  22. Class-specific human bactericidal antibodies to capsular and noncapsular surface antigens of Neisseria meningitidis.
    J Infect Dis. 1984 Mar;149(3):387-96 PMID: 6425422
  23. Safety of vaccines containing meningococcal group B polysaccharide.
    Lancet. 1984 Jul 21;2(8395):166 PMID: 6146064
  24. Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age.
    N Engl J Med. 1977 Sep 29;297(13):686-91 PMID: 408682
Article Info
Journal
European journal of clinical microbiology
Abbr.
Eur J Clin Microbiol
ISSN
0722-2211
DOI
10.1007/BF02013388
Published
1985-12-00
Pages
533-6
Language
English
Region
Germany
NLM ID
8219582
Subset
IM
External Links
PubMed source DOI: 10.1007/BF02013388
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2